Last reviewed · How we verify
Gram-Negative Bacterial Infections
Approved treatments
- Fetroja · Shionogi
Fetroja works by binding to penicillin-binding proteins on bacterial cell walls, inhibiting cell wall synthesis and ultimately leading to bacterial cell death.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Gram-Negative Bacterial Infections patent landscape — cliff calendar, originator estates, attackable patents
- Gram-Negative Bacterial Infections treatment landscape brief
- Gram-Negative Bacterial Infections treatment updates RSS
Frequently asked questions about Gram-Negative Bacterial Infections
What drugs treat Gram-Negative Bacterial Infections?
Tracked treatments include Fetroja.
What is the treatment for Gram-Negative Bacterial Infections?
Standard treatment for Gram-Negative Bacterial Infections includes Fetroja. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Gram-Negative Bacterial Infections patent cliff · Gram-Negative Bacterial Infections CI report
- Treatment: Fetroja · Shionogi
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing